White Guide and Orange Guide Formatting Project - Pfizer

Questions From a P&T Committee Member About Their Status
Orange Guide – Chapter 7: P&T Committee Interactions
Q. If a physician asks if I know whether he or she is a P&T Committee member,
what should I say?
A. Always answer truthfully. While P&T Committee members often do not wish to
be identified as such, answering honestly is the best way for you to
demonstrate the core value of integrity with the HCP.
Buying Lunch for a P&T Committee Member
Q. If I run into a member of a P&T Committee in the hall at a hospital, may I offer
to buy him or her lunch and discuss the benefits of a Pfizer product while we
eat?
A. Yes, as long as the hospital's P&T Committee does not restrict this type of
interaction. Your interactions with P&T Committee members are governed by
the same Pfizer policies that govern your interactions with HCPs. If the hospital
doesn't prohibit it, Pfizer policy permits you to engage in a product promotional
discussion over an occasional modest meal. Pursuant to the PhRMA Code and
Pfizer policy, field colleagues (PHRs, TSRs, DMs, and CSs) may only provide a
meal to HCPs at in-office or in-hospital settings and in conjunction with
informational presentations/discussions.
Calling on a P&T Committee Member Not in Call Cycle
Q. A physician on a state Medicaid P&T Committee is in my territory but is not part
of my normal call cycle due to low prescribing potential. Can I still call on him
to discuss the clinical benefits of my products as they relate to his Medicaid
duties?
A. Maybe. Presenting product information to an HCP who is a member of a state
Medicaid P&T Committee is appropriate as long as the guidelines in this
Chapter are followed. However, you should consult with your manager before
adding the HCP to your call cycle.
Calling on a P&T Committee Member During a Formulary Decision
Q. If an HCP who is a P&T Committee member is part of my normal call cycle, can I
call on the HCP more frequently when I know that there is a pending formulary
decision for one of the products I carry?
A. Maybe. Increasing the number of calls to the HCP in and of itself is not
considered "special treatment" and may be appropriate so long as the
provisions of this Chapter are followed and the purpose for the increase in call
volume is to provide relevant on-label information for the HCP to consider in
making a decision. However, you should consult with your manager before
deciding to call on an HCP more frequently under these circumstances.
127
Rev. 09/12
Page 5 of 11